Walleye Trading’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$849K Sell
2,900
-19,500
-87% -$6.41M ﹤0.01% 2250
2025
Q4
$7.85M Sell
22,400
-2,700
-11% -$912K 0.01% 1045
2025
Q3
$8.11M Sell
25,100
-42,200
-63% -$13.1M 0.01% 1001
2025
Q2
$26.2M Buy
67,300
+37,200
+124% +$15M 0.05% 426
2025
Q1
$13.1M Buy
30,100
+14,000
+87% +$5.62M 0.03% 595
2024
Q4
$5.94M Sell
16,100
-11,100
-41% -$4.64M 0.01% 1050
2024
Q3
$14.1M Buy
27,200
+8,700
+47% +$4.65M 0.03% 606
2024
Q2
$10M Buy
18,500
+4,800
+35% +$2.54M 0.02% 675
2024
Q1
$7.1M Sell
13,700
-12,600
-48% -$6.27M 0.02% 902
2023
Q4
$12.4M Sell
26,300
-22,200
-46% -$10.3M 0.03% 657
2023
Q3
$21.1M Buy
48,500
+27,100
+127% +$12.3M 0.06% 347
2023
Q2
$9.51M Sell
21,400
-29,000
-58% -$13.4M 0.03% 604
2023
Q1
$23.2M Buy
50,400
+35,700
+243% +$17M 0.05% 337
2022
Q4
$7.54M Sell
14,700
-4,700
-24% -$2.39M 0.02% 824
2022
Q3
$8.81M Sell
19,400
-18,200
-48% -$8.71M 0.03% 689
2022
Q2
$18.1M Buy
37,600
+29,800
+382% +$14.7M 0.06% 355
2022
Q1
$3.83M Sell
7,800
-3,100
-28% -$1.42M 0.01% 1178
2021
Q4
$5.05M Buy
10,900
+7,100
+187% +$2.99M 0.02% 972
2021
Q3
$1.42M Sell
3,800
-1,200
-24% -$456K 0.01% 1886
2021
Q2
$1.91M Sell
5,000
-2,200
-31% -$841K 0.01% 1540
2021
Q1
$2.58M Sell
7,200
-5,000
-41% -$1.61M 0.01% 1127
2020
Q4
$3.92M Sell
12,200
-300
-2% -$92.1K 0.02% 884
2020
Q3
$3.36M Buy
12,500
+12,000
+2,400% +$3.23M 0.02% 793
2020
Q2
$131K Sell
500
-3,400
-87% -$907K ﹤0.01% 3350
2020
Q1
$885K Sell
3,900
-8,700
-69% -$2.37M 0.01% 1388
2019
Q4
$3.81M Buy
12,600
+5,600
+80% +$1.54M 0.03% 742
2019
Q3
$1.68M Sell
7,000
-4,400
-39% -$1.21M 0.01% 1195
2019
Q2
$3.22M Buy
11,400
+800
+8% +$219K 0.03% 719
2019
Q1
$3.04M Buy
10,600
+1,600
+18% +$463K 0.02% 780
2018
Q4
$2.36M Sell
9,000
-18,100
-67% -$4.98M 0.02% 943
2018
Q3
$7.43M Sell
27,100
-14,900
-35% -$3.87M 0.04% 451
2018
Q2
$10M Buy
42,000
+17,000
+68% +$3.94M 0.05% 295
2018
Q1
$5.49M Buy
25,000
+9,400
+60% +$2.21M 0.03% 496
2017
Q4
$3.52K Sell
15,600
-7,700
-33% -$1.64M 0.02% 886
2017
Q3
$4.43K Sell
23,300
-6,400
-22% -$1.22M 0.02% 737
2017
Q2
$5.59K Buy
29,700
+22,800
+330% +$4.1M 0.03% 511
2017
Q1
$1.14K Buy
6,900
+1,300
+23% +$207K 0.01% 1529
2016
Q4
$805K Buy
5,600
+1,400
+33% +$187K 0.01% 1691
2016
Q3
$526K Sell
4,200
-26,600
-86% -$3.43M ﹤0.01% 2093
2016
Q2
$4.04M Buy
30,800
+7,500
+32% +$1.03M 0.03% 565
2016
Q1
$3.24M Sell
23,300
-57,900
-71% -$7.74M 0.03% 574
2015
Q4
$11.3M Buy
81,200
+42,900
+112% +$5.91M 0.11% 173
2015
Q3
$5.36M Buy
38,300
+33,600
+715% +$5.05M 0.05% 287
2015
Q2
$771K Buy
4,700
+2,900
+161% +$463K 0.01% 1315
2015
Q1
$278K Sell
1,800
-1,800
-50% -$256K ﹤0.01% 1947
2014
Q4
$452K Sell
3,600
-200
-5% -$24.7K ﹤0.01% 1657
2014
Q3
$455K Sell
3,800
-5,200
-58% -$596K 0.01% 1411
2014
Q2
$969 Buy
9,000
+8,700
+2,900% +$896K 0.01% 823
2014
Q1
$30 Sell
300
-5,700
-95% -$516K ﹤0.01% 2926
2013
Q4
$554K Sell
6,000
-1,900
-24% -$169K 0.01% 1496
2013
Q3
$659K Sell
7,900
-6,000
-43% -$514K 0.01% 1068
2013
Q2
$1.14M Buy
+13,900
New +$1.04M 0.01% 835

Other funds holding ELV

Walleye Trading's ELV Position: Q1 2026 in Review

Walleye Trading increased its Elevance Health (ELV) stake by 8% in Q1 2026, buying an estimated $59.8K and bringing the position to 2,457 shares worth $719K. The position accounts for ﹤0.01% of the portfolio, ranked #2350.

Walleye Trading first reported a position in ELV in Q2 2013 and has held it in 30 quarters since. The position peaked at $11.2M in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Walleye Trading held 2,457 shares of Elevance Health worth $719K as of Q1 2026.
  • Walleye Trading bought 182 Elevance Health shares in Q1 2026, an estimated $59.8K.
  • Elevance Health made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2350 holding.
  • Walleye Trading first reported a position in Elevance Health in Q2 2013 and has held it in 30 quarters since.
  • Walleye Trading's Elevance Health position peaked at $11.2M in Q4 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.